AR100DP1

· Arjil Pharmaceuticals LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AR100DP1, covering 2023-12-11 to 2023-12-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study for AR100DP1 in Mild to Moderate Atopic Dermatitis (AD) [Phase 1, Phase 2]